Racial minorities have reduced access to high-quality joint replacement care, according to Dr. Xueya Cai and colleagues from the University of Iowa in the US. Their work, published online in Springer's journal Clinical Orthopaedics ...
Sep 13, 2011
1
0
An effective drug to treat chronic heart failure may cost too much for senior citizens with a standard Medicare Part D drug plan, said a study co-authored by a John A. Burns School of Medicine (JABSOM) researcher at the University ...
Jul 23, 2019
0
2
Cost of radiation therapy among Medicare patients varied most widely because of factors unrelated to a patient or that person's cancer, report University of California, San Diego School of Medicine researchers in the Journal ...
Aug 11, 2015
0
5
Two drugs that treat macular degeneration are practically interchangeable - except for the price.
Feb 2, 2015
0
10
(HealthDay)—Expensive medications are being given far more often to elderly patients with metastatic colorectal cancer, but they offer almost no benefit, according to a study published online Feb. 19 in Medical Care.
Mar 11, 2016
0
2
In the United States, older patients with advanced lung cancer make much less use of hospital and emergency room services at the end of life than their counterparts in Ontario but use far more chemotherapy, according to a ...
May 18, 2011
0
0
(HealthDay)—Despite years of attention to the problem, U.S. hospitals have made little headway in preventing severe cases of bedsores among older Americans, a new study shows.
Nov 7, 2018
0
4
Most heart attack patients transferred between hospitals for the emergency artery-opening procedure called angioplasty are not transported as quickly as they should be, Yale School of medicine researchers report in the first ...
Nov 28, 2011
0
0
Hospitals, doctors and Medicare Advantage insurance plans that care for some of the most vulnerable patients are not reimbursed fairly by Medicare, according to recent findings in JAMA.
Feb 7, 2020
0
2
Medicare patients with multiple sclerosis face skyrocketing out-of-pocket costs for therapies due to complicated insurance rules that force them to pick up an increasing share of the cost, according to new research.
Feb 4, 2019
0
15
